Title : Response to erlotinib and bevacizumab combination therapy after acquired resistance to osimertinib in patients with non-small cell lung cancer.

Pub. Date : 2022 Mar 1

PMID : 34974477






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Osimertinib is the most reliable epidermal growth factor receptor-tyrosine kinase (EGFR-TKI) and is recommended as the first-line EGFR-TKI. osimertinib epidermal growth factor receptor Homo sapiens
2 Osimertinib is the most reliable epidermal growth factor receptor-tyrosine kinase (EGFR-TKI) and is recommended as the first-line EGFR-TKI. osimertinib epidermal growth factor receptor Homo sapiens